Both IGHV mutated and unmutated CLL prognostic groups showed significantly hypermethylated specific peak in the TET1 intronic region compared to normal sorted B cell sample (Figure 1A). This evidence concerns the gene TET1 and B-cell chronic lymphocytic leukemia.